Atlas Trials

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Clinical trial NCT02093910 · UNKNOWN

Trial details

NCT number
NCT02093910
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-04-01
Primary completion
2017-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.